Our Advantages
Unique T cell gene screening and editing platform
-
Leading CGT Team
Academician + CEO
40+ employees，with over 70% in R&D, most of them are PhDs and masters
-
Our Pipelines
Scientific driven, discover FIC/BIC targets to reduce T-cell exhaustion
Pipeline includes multiple TIL and Treg products, with two products already in or about to enter clinical trials
-
Innovative Technology Platform
Cutting-edge TIL product rapid process platform
Novel gene-edited TIL GMP production platform
Product Pipeline
Dedicated to tackling unresolved challenges such as solid tumors and autoimmune diseases
-
Pipeline
-
Category
-
Indication
-
Mechanism
-
Early Discovery
-
POC
-
Pre-clinical
-
IIT
-
IND
-
-
Ben-102
Ben-201
Ben-202
Ben-203
Ben-204
-
TIL/ Engineered-TIL
-
Solid Tumor
-
/
Enhancing T Cell Proliferation, Killing, and Cytokine Secretion
Enhancing T Cell Proliferation and Reducing Exhaustion
Increasing Stem-Like T Cell and Anti-tumor Ability
Increasing CD8 T Cell Survival and Cytotoxicity
-
-
-
-
Ben-301
-
Engineered-Treg
-
AID
-
Regulating T and B cell Functions
-
-
Pipeline：Ben-301
Category：TIL/ Engineered-TIL
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：/
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Enhancing T Cell Proliferation, Killing, and Cytokine Secretion
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Enhancing T Cell Proliferation and Reducing Exhaustion
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Increasing Stem-Like T Cell and Anti-tumor Ability
Indication：Solid Tumor
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Increasing CD8 T Cell Survival and Cytotoxicity
Pipeline：Ben-204
Category：Engineered-Treg
Indication：AID
Early Discovery
POC
Pre-clinical
IIT
IND
Mechanism：Regulating T and B cell Functions
Technology Platforms
-
nu-TECH
Utilize engineering techniques to mitigate T cell exhaustion, augment stemness, and amplify functional T cells
The utilization of cutting-edge technology and gene editing techniques is employed to enhance the desiccation resistance and memory capacity of T cells, thereby decelerating their depletion rate. This approach aims to achieve rapid expansion of functional T cells and augment their cytotoxicity.
Learn More
nu-TECH
-
nu-GENE
Cutting-edge T-cell target screening and gene editing platform for unique immunotherapy with precise experimental cell manipulation.
Through T-cell engineering and the establishment of unique in vitro and in vivo models, our objective is to achieve precise and functional assessment of T-cell immunotherapy.
Learn More
nu-GENE
Join Us